**FOREIGN PRODUCERS' QUESTIONNAIRE**

**GLYCINE FROM INDIA, JAPAN, AND KOREA**

***Return completed questionnaire (hard copy or saved to CD) to:***

**UNITED STATES INTERNATIONAL TRADE COMMISSION**

Office of Investigations, Room 615-U

500 E Street, SW, Washington, DC 20436

**So as to be received by the Commission by no later than October 17,
2007**

The information called for in this questionnaire is for use by the
United States International Trade Commission in connection with its
antidumping investigations concerning glycine from India, Japan, and
Korea (inv. Nos. 731-TA-1111-1113 (Final)). The information requested in
the questionnaire is requested under the authority of the Tariff Act of
1930, title VII.

+-----------------------------------------------------------------------+
| > **Name of firm** [     ]{.underline}                                |
| >                                                                     |
| > **Address** [     ]{.underline}                                     |
| >                                                                     |
| > **City** [     ]{.underline} **Country** [     ]{.underline} **Zip  |
| > Code** [     ]{.underline}                                          |
| >                                                                     |
| > **World Wide Web address** [     ]{.underline}                      |
| >                                                                     |
| > Has your firm produced or exported glycine (as defined in the       |
| > instruction booklet) at any time since January 1, 2004?             |
| >                                                                     |
| > **NO** (Sign the certification below and promptly return only this  |
| > page of the questionnaire to the Commission)                        |
| >                                                                     |
| > **YES** (Read the instruction booklet carefully, complete all parts |
| > of the questionnaire, and return the entire                         |
| >                                                                     |
| > questionnaire to the Commission so as to be received by the date    |
| > indicated above)                                                    |
+-----------------------------------------------------------------------+

**CERTIFICATION**

***I certify that the information herein supplied in response to this
questionnaire is complete and correct to the best of my knowledge and
belief and understand that the information submitted is subject to audit
and verification by the Commission.***

***By submitting this certification I also grant consent for the
Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout these
investigations in any other import-injury investigations conducted by
the Commission on the same or similar merchandise.***

***I acknowledge that information submitted in this questionnaire
response and throughout these investigations may be used by the
Commission, its employees, and contract personnel who are acting in the
capacity of Commission employees, for developing or maintaining the
records of these investigations or related proceedings for which this
information is submitted, or in internal audits and investigations
relating to the programs and operations of the Commission pursuant to 5
U.S.C. Appendix 3. I understand that all contract personnel will sign
non-disclosure agreements.***

[     ]{.underline} [     ]{.underline} [     ]{.underline}

***Name of Authorized Official*** ***Title of Authorized Official
Date***

[     ]{.underline} ***Phone:*** [(   )     ]{.underline} ***E-mail:***
[     ]{.underline}

***Signature***

***Fax*** [(   )     ]{.underline}

The questions in this questionnaire have been reviewed with market
participants to ensure that issues of concern are adequately addressed
and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to
average 30 hours per response, including the time for reviewing
instructions, searching existing data sources, gathering the data
needed, and completing and reviewing the questionnaire. Send comments
regarding the accuracy of this burden estimate or any other aspect of
this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade
Commission, 500 E Street, SW, Washington, DC 20436.

I-1a. Please report below the actual number of hours required and the
cost to your firm of preparing the reply to this questionnaire and
completing the form.

[     ]{.underline} hours [     ]{.underline} dollars

I-1b. We are interested in any comments you may have for improving this
questionnaire in general or the clarity of specific questions. Please
attach such comments to your response or send them to the above address.

I-2. Provide the name and address of establishment(s) covered by this
questionnaire (see pages 3-4 of the instruction booklet for reporting
guidelines). If your firm is publicly traded, please specify the stock
exchange and trading symbol.

> [     \
> ]{.underline}

I-3. Please provide the names, street addresses (not P.O. boxes),
contacts, telephone numbers, and e-mail addresses of the
**[FIVE]{.underline}** largest U.S. importers of your firm's glycine in
the January 2004 to June 2007 period.

+---+-------------+-------------+------------------+-------+--------+
| * | *           | **Contact   | **Email**        | *     | *      |
| * | *Importer's | Person**    |                  | *Area | *Share |
| N | Name**      |             |                  | code  | of     |
| o |             |             |                  | and   | J      |
| . |             |             |                  | tele  | anuary |
| * |             |             |                  | phone | 2004   |
| * |             |             |                  | num   | to     |
|   |             |             |                  | ber** | June   |
|   |             |             |                  |       | 2007   |
|   |             |             |                  |       | exp    |
|   |             |             |                  |       | orts** |
|   |             |             |                  |       |        |
|   |             |             |                  |       | *      |
|   |             |             |                  |       | *(%)** |
+---+-------------+-------------+------------------+-------+--------+
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
| 1 |             |             |                  |       |        |
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
+---+-------------+-------------+------------------+-------+--------+
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
| 2 |             |             |                  |       |        |
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
+---+-------------+-------------+------------------+-------+--------+
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
| 3 |             |             |                  |       |        |
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
+---+-------------+-------------+------------------+-------+--------+
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
| 4 |             |             |                  |       |        |
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
+---+-------------+-------------+------------------+-------+--------+
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
| 5 |             |             |                  |       |        |
| * |             |             |                  |       |        |
| * |             |             |                  |       |        |
+---+-------------+-------------+------------------+-------+--------+

I-4. Does your firm, or any related firm, produce, have the capability
to produce, or have any plans to produce, glycine in the United States
or other countries?

> No Yes\--Please name the firm(s) and country(ies) below and, if
> U.S.producer(s), ensure that they complete the Commission's U.S.
> producers' questionnaire (contact Russell Duncan for copies of that
> questionnaire).
>
> [     \
> \
> ]{.underline}

I-5. Does your firm, or any related firm, import or have any plans to
import glycine into the United States?

> No Yes\--Please name the firm(s) below and ensure that they complete
> the Commission's U.S. importers' questionnaire (contact Russell Duncan
> for copies of that questionnaire).
>
> [     \
> \
> ]{.underline}

Further information on this part of the questionnaire can be obtained
from Russell Duncan (202-708-4727; <russell.duncan@usitc.gov>).
**Supply** **all data requested on a [calendar-year]{.underline}
basis**.

II-1. Who should be contacted regarding the requested trade and related
information?

> Company contact: [     ]{.underline}
>
> Name and title
>
> [(   )      ]{.underline} [     ]{.underline}
>
> Phone number E-mail address

II-2. Does your firm have any plans to add, expand, curtail, or shut
down production capacity and/or production of glycine in India, Japan,
or Korea?

> No Yes\--Please describe those plans, including planned dates and
> capacity/ production quantities involved, and the reason(s) for such
> change(s). If the plans are to add or expand capacity or production,
> list (in descending order of importance) the markets (countries) to
> which such additional capacity or production would be directed.
>
> [     \
> ]{.underline}

II-3. What percentage of your firm's total sales in its most recent
fiscal year was represented by sales of glycine?

[     ]{.underline} Percent

II-4. Does your firm produce products other than glycine on the same
equipment and machinery used in the production of glycine?

> No Yes\--List the following information.
>
> Basis for allocation of capacity data (*e.g.*, sales):
> [     ]{.underline}
>
> Products produced on same equipment and share of total production in
> 2006 (in percent):

  ----------------------------------------------- ---------------------------
  **[Product]{.underline}**                       **[Percent]{.underline}**

  [Glycine]{.underline}                           [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}

  [     ]{.underline}                             [     ]{.underline}
  ----------------------------------------------- ---------------------------

II-5. Has your firm maintained any inventories of glycine in the United
States (not including inventories held by firms identified in questions
I-3, I-4, or I-5 above[^1]) since 2004?

> No Yes\--Report the quantity (in 1,000 pounds) of such end-of-period
> inventories below.

  --------------------- --------------------- --------------------- --------------------- ---------------------
  **2004**              **2005**              **2006**              **Jan Jun 2006**      **Jan-Jun 2007**

  [     ]{.underline}   [     ]{.underline}   [     ]{.underline}   [     ]{.underline}   [     ]{.underline}
  --------------------- --------------------- --------------------- --------------------- ---------------------

II-6. Is the glycine exported by your firm subject to antidumping
findings or remedies in any WTO-member countries?

> No Yes\--List the products(s), countries affected, and the date of
> such findings/remedies.

  ----------------------------------- --------------------- ---------------------
  **Product**                         **Country**           **Date**

  [     ]{.underline}                 [     ]{.underline}   [     ]{.underline}

  [     ]{.underline}                 [     ]{.underline}   [     ]{.underline}

  [     ]{.underline}                 [     ]{.underline}   [     ]{.underline}

  [     ]{.underline}                 [     ]{.underline}   [     ]{.underline}

  [     ]{.underline}                 [     ]{.underline}   [     ]{.underline}
  ----------------------------------- --------------------- ---------------------

II-7. Please indicate which production process your firm uses to produce
glycine. (check all that apply)

> **[Hydrogen cyanide ("HCN") process]{.underline}** \-- (This process
> uses formaldehyde, hydrogen cyanide, aqueous ammonia, sodium
> hydroxide, and sulfuric acid as raw material inputs and/or catalysts
> to produce glycine. Sodium glycinate is a distinct intermediate
> product in this process.)
>
> **[Monochloracetic acid ("MCA") process]{.underline}** \-- (This
> process uses ammonium chloride, monochloracetic acid, and
> hexamethyleneteramine as raw material inputs and/or catalysts to
> produce glycine. Sodium glycinate is *[not]{.underline}* an
> intermediate product in this production process.)
>
> **[Other]{.underline}**\--Please describe: [     ]{.underline}

II-8. Report your firm's production capacity, production, shipments,
inventories, and employment related to the production of glycine in your
U.S. establishment(s) during the specified periods. (See definitions in
the instruction booklet.)

+-----------------------+-----+-----+-----+-----+------+-----+-----+
| **Quantity (*in 1,000 |     |     |     |     |      |     |     |
| pounds*)**            |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| **Item**              | **  |     |     |     |      | **P |     |
|                       | Act |     |     |     |      | roj |     |
|                       | ual |     |     |     |      | ect |     |
|                       | exp |     |     |     |      | ion |     |
|                       | eri |     |     |     |      | s** |     |
|                       | enc |     |     |     |      |     |     |
|                       | e** |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
|                       | *   |     |     | *   |      | *   |     |
|                       | *Ca |     |     | *Ja |      | *Ca |     |
|                       | len |     |     | nua |      | len |     |
|                       | dar |     |     | ry- |      | dar |     |
|                       | yea |     |     | Jun |      | yea |     |
|                       | r** |     |     | e** |      | r** |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
|                       | **  | **  | **  | **  | **20 | **  | **  |
|                       | 200 | 200 | 200 | 200 | 07** | 200 | 200 |
|                       | 4** | 5** | 6** | 6** |      | 7** | 8** |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| ***For producers:***  |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Average           |     |     |     |     |      |     |     |
| > production          |     |     |     |     |      |     |     |
| > capacity**^1^       |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Production**^3^   |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| ***For producers and  |     |     |     |     |      |     |     |
| exporters:***         |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| >                     |     |     |     |     |      |     |     |
| **Beginning-of-period |     |     |     |     |      |     |     |
| > inventories**^2^    |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Shipments:**      |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Internal          |     |     |     |     |      |     |     |
| > co                  |     |     |     |     |      |     |     |
| nsumption/transfers** |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Home market       |     |     |     |     |      |     |     |
| > shipments**         |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Exports to\--**   |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **United            |     |     |     |     |      |     |     |
| > States**^4^         |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **European          |     |     |     |     |      |     |     |
| > Union**^5^          |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Asia**^6^         |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **All other export  |     |     |     |     |      |     |     |
| > markets**^7^        |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Total exports**   |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **Total shipments** |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| > **End-of-period     |     |     |     |     |      |     |     |
| > inventories**       |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+
| ^1^ The production    |     |     |     |     |      |     |     |
| capacity (see         |     |     |     |     |      |     |     |
| definitions in        |     |     |     |     |      |     |     |
| instruction booklet)  |     |     |     |     |      |     |     |
| reported is based on  |     |     |     |     |      |     |     |
| operating             |     |     |     |     |      |     |     |
| [     ]{.underline}   |     |     |     |     |      |     |     |
| hours per week,       |     |     |     |     |      |     |     |
| [     ]{.underline}   |     |     |     |     |      |     |     |
| weeks per year.       |     |     |     |     |      |     |     |
| Please describe the   |     |     |     |     |      |     |     |
| methodology used to   |     |     |     |     |      |     |     |
| calculate production  |     |     |     |     |      |     |     |
| capacity, and explain |     |     |     |     |      |     |     |
| any changes in        |     |     |     |     |      |     |     |
| reported capacity.    |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| [     ]{.underline}   |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| ^2^ Reconciliation of |     |     |     |     |      |     |     |
| data.\--Please note   |     |     |     |     |      |     |     |
| that the              |     |     |     |     |      |     |     |
| **quantities**        |     |     |     |     |      |     |     |
| reported above should |     |     |     |     |      |     |     |
| reconcile as follows: |     |     |     |     |      |     |     |
| beginning-of-period   |     |     |     |     |      |     |     |
| inventories, plus     |     |     |     |     |      |     |     |
| production, less      |     |     |     |     |      |     |     |
| total shipments,      |     |     |     |     |      |     |     |
| equals end-of-period  |     |     |     |     |      |     |     |
| inventories. Do the   |     |     |     |     |      |     |     |
| data reported         |     |     |     |     |      |     |     |
| reconcile?            |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| Yes No\--Please       |     |     |     |     |      |     |     |
| explain:              |     |     |     |     |      |     |     |
| [     ]{.underline}   |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| ^3^ Please estimate   |     |     |     |     |      |     |     |
| the percentage of     |     |     |     |     |      |     |     |
| total production of   |     |     |     |     |      |     |     |
| glycine in India,     |     |     |     |     |      |     |     |
| Japan, or Korea       |     |     |     |     |      |     |     |
| accounted for by your |     |     |     |     |      |     |     |
| firm's production in  |     |     |     |     |      |     |     |
| 2006.                 |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| [     ]{.underline}   |     |     |     |     |      |     |     |
| Percent               |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| ^4^ Please estimate   |     |     |     |     |      |     |     |
| the percentage of     |     |     |     |     |      |     |     |
| total exports to the  |     |     |     |     |      |     |     |
| United States of      |     |     |     |     |      |     |     |
| glycine from India,   |     |     |     |     |      |     |     |
| Japan, or Korea       |     |     |     |     |      |     |     |
| accounted for by your |     |     |     |     |      |     |     |
| firm's exports in     |     |     |     |     |      |     |     |
| 2006.                 |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| [     ]{.underline}   |     |     |     |     |      |     |     |
| Percent               |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| ^5^ Identify          |     |     |     |     |      |     |     |
| principal European    |     |     |     |     |      |     |     |
| Union export markets. |     |     |     |     |      |     |     |
| [     ]{.underline} . |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| ^6^ Identify          |     |     |     |     |      |     |     |
| principal Asian       |     |     |     |     |      |     |     |
| export markets.       |     |     |     |     |      |     |     |
| [     ]{.underline} . |     |     |     |     |      |     |     |
|                       |     |     |     |     |      |     |     |
| ^7^ Identify          |     |     |     |     |      |     |     |
| principal other       |     |     |     |     |      |     |     |
| export markets.       |     |     |     |     |      |     |     |
| [     ]{.underline} . |     |     |     |     |      |     |     |
+-----------------------+-----+-----+-----+-----+------+-----+-----+

II-9. Does your firm manufacture sodium glycinate that is not then used
to produce glycine?

> No Yes\--Please describe the end uses of sodium glycinate *[other
> than]{.underline}* for the production of glycine.
>
> [     \
> ]{.underline}

II-10. Report your firm's exports to the United States of glycine and
its precursors by grade (as defined in the instructions booklet).

+-------------------------------+------+------+------+------+------+
| **Quantity (*in 1,000         |      |      |      |      |      |
| pounds*)**                    |      |      |      |      |      |
+-------------------------------+------+------+------+------+------+
| **Item**                      | **   |      |      | **Ja |      |
|                               | Cale |      |      | nuar |      |
|                               | ndar |      |      | y-Ju |      |
|                               | ye   |      |      | ne** |      |
|                               | ar** |      |      |      |      |
+-------------------------------+------+------+------+------+------+
|                               | **20 | **20 | **20 | **20 | **20 |
|                               | 04** | 05** | 06** | 06** | 07** |
+-------------------------------+------+------+------+------+------+
| **Exports to the United       |      |      |      |      |      |
| States \--^1^**               |      |      |      |      |      |
+-------------------------------+------+------+------+------+------+
| > Pharmaceutical grade        |      |      |      |      |      |
| > glycine:^2^                 |      |      |      |      |      |
+-------------------------------+------+------+------+------+------+
| > USP grade glycine:^2^       |      |      |      |      |      |
|                               |      |      |      |      |      |
+-------------------------------+------+------+------+------+------+
| > Technical grade glycine:^2^ |      |      |      |      |      |
|                               |      |      |      |      |      |
+-------------------------------+------+------+------+------+------+
| > Sodium glycinate:^3^        |      |      |      |      |      |
|                               |      |      |      |      |      |
+-------------------------------+------+------+------+------+------+
| ^1^ The sum of these grades   |      |      |      |      |      |
| of glycine and of sodium      |      |      |      |      |      |
| glycinate in this table       |      |      |      |      |      |
| should correspond to the      |      |      |      |      |      |
| quantities and values for     |      |      |      |      |      |
| U.S. commercial shipments as  |      |      |      |      |      |
| reported in response to       |      |      |      |      |      |
| question II-7.                |      |      |      |      |      |
|                               |      |      |      |      |      |
| ^2^ As defined in the         |      |      |      |      |      |
| instructions booklet. These   |      |      |      |      |      |
| grades of glycine may be      |      |      |      |      |      |
| shipped in either in solid or |      |      |      |      |      |
| liquid forms.                 |      |      |      |      |      |
|                               |      |      |      |      |      |
| ^3^ As defined in the         |      |      |      |      |      |
| instructions booklet.         |      |      |      |      |      |
+-------------------------------+------+------+------+------+------+

[^1]: ^?^ Such firms will report inventories in the Commission's
    importer or producer questionnaire.